CHEBI:90239 - tiazofurine

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name tiazofurine
ChEBI ID CHEBI:90239
Definition A C-glycosyl compound that is 1,3-thiazole-4-carboxamide in which the hydrogen at position 2 has been replaced by a β-D-ribofuranosyl group. It is metabolised to thiazole-4-carboxamide adenine dinucleotide (TAD), a selective inhibitor of inosine monophosphate dehydrogenase (IMP dehydrogenase).
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information ZINC000004217560
Download Molfile XML SDF
more structures >>
Wikipedia License
Tiazofurin is a drug which acts as an inhibitor of the enzyme IMP dehydrogenase. Tiazofurin and its analogues were under investigation for potential use in the treatment of cancer, though side effects such as pleuropericarditis and a flu-like syndrome precluded further development. They also show antiviral effects and may be reevaluated as potential options in the treatment of newly emerging viral diseases.
Read full article at Wikipedia
Formula C9H12N2O5S
Net Charge 0
Average Mass 260.268
Monoisotopic Mass 260.04669
InChI InChI=1S/C9H12N2O5S/c10-8(15)3-2-17-9(11-3)7-6(14)5(13)4(1-12)16-7/h2,4-7,12-14H,1H2,(H2,10,15)/t4-,5-,6-,7-/m1/s1
InChIKey FVRDYQYEVDDKCR-DBRKOABJSA-N
SMILES O1[C@@H](C=2SC=C(N2)C(N)=O)[C@H](O)[C@H](O)[C@H]1CO
Roles Classification
Biological Role(s): EC 1.1.1.205 (IMP dehydrogenase) inhibitor
An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD+ or NADP+ acceptor) inhibitor that interferes with the action of IMP dehydrogenase (EC 1.1.1.205), so blocking de novo biosynthesis of purine nucleotides.
Application(s): prodrug
A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing tiazofurine (CHEBI:90239) has functional parent β-D-ribose (CHEBI:47002)
tiazofurine (CHEBI:90239) has role antineoplastic agent (CHEBI:35610)
tiazofurine (CHEBI:90239) has role EC 1.1.1.205 (IMP dehydrogenase) inhibitor (CHEBI:53746)
tiazofurine (CHEBI:90239) has role prodrug (CHEBI:50266)
tiazofurine (CHEBI:90239) is a 1,3-thiazoles (CHEBI:38418)
tiazofurine (CHEBI:90239) is a C-glycosyl compound (CHEBI:20857)
tiazofurine (CHEBI:90239) is a monocarboxylic acid amide (CHEBI:29347)
IUPAC Name
(1R)-1,4-anhydro-1-(4-carbamoyl-1,3-thiazol-2-yl)-D-ribitol
INNs Sources
tiazofurina WHO MedNet
tiazofurine WHO MedNet
tiazofurine WHO MedNet
tiazofurinum WHO MedNet
Synonyms Sources
2-(β-D-ribofuranosyl)-4-thiazolecarboxamide ChEBI
2-β-D-ribofuranosyl-4-thiazolecarboxamide ChemIDplus
CI-909 ChemIDplus
riboxamide ChemIDplus
TCAR ChEBI
tiazofurin KEGG DRUG
Manual Xrefs Databases
D06130 KEGG DRUG
Tiazofurin Wikipedia
TIZ PDBeChem
View more database links
Registry Numbers Types Sources
1084555 Reaxys Registry Number Reaxys
60084-10-8 CAS Registry Number ChemIDplus
Citations
Kusumanchi P, Zhang Y, Jani MB, Jayaram NH, Khan RA, Tang Y, Antony AC, Jayaram HN (2013)
Nicotinamide mononucleotide adenylyltransferase2 overexpression enhances colorectal cancer cell-kill by Tiazofurin.
Cancer gene therapy 20, 403-412 [PubMed:23764899]
[show Abstract]
Grifantini M (2000)
Tiazofurine ICN Pharmaceuticals.
Current opinion in investigational drugs (London, England : 2000) 1, 257-262 [PubMed:11249583]
[show Abstract]
Mitrović DM, Redzić ZB, Marković ID, Jovanović SS, Rosić MA, Rakić LM (1995)
Tiazofurine uptake by the isolated guinea pig heart.
Journal of chemotherapy (Florence, Italy) 7, 543-548 [PubMed:8667040]
[show Abstract]
Nagy PD, Gáborjányi R, Kovács L, Farkas I (1989)
Antiviral activity of tiazofurine against barley stripe mosaic virus.
Antiviral research 11, 41-45 [PubMed:2712550]
[show Abstract]
Last Modified
05 November 2015